{
  "_metadata": {
    "version": "1.0.0",
    "last_updated": "2026-03-01",
    "sources": [
      "Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389(10081):1778-1780.",
      "Kalisch Ellett LM, et al. Prescribing cascades: an overlooked cause of polypharmacy in older adults. J Am Geriatr Soc. 2014.",
      "McCarthy LM, et al. Prescribing cascades in community-dwelling older adults: a systematic review. BMC Geriatrics. 2022."
    ],
    "definition": "A prescribing cascade occurs when a new medication is prescribed to treat an adverse drug reaction (ADR) that was mistakenly interpreted as a new medical condition.",
    "maintainer": "PGx Clinical Solutions"
  },
  "cascades": [
    {
      "id": "CASCADE_01",
      "name": "CCB → Peripheral Edema → Diuretic",
      "trigger_drugs": ["amlodipine", "nifedipine", "felodipine"],
      "trigger_class": "calcium_channel_blocker",
      "adverse_effect": "peripheral_edema",
      "cascade_drugs": ["furosemide", "hydrochlorothiazide", "bumetanide"],
      "cascade_class": "diuretic",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "Consider dose reduction of CCB or switch to ACE inhibitor/ARB. Edema is dose-dependent side effect, not heart failure.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_02",
      "name": "Cholinesterase Inhibitor → Urinary Incontinence → Anticholinergic",
      "trigger_drugs": ["donepezil", "rivastigmine", "galantamine"],
      "trigger_class": "cholinesterase_inhibitor",
      "adverse_effect": "urinary_incontinence",
      "cascade_drugs": ["oxybutynin", "tolterodine", "solifenacin"],
      "cascade_class": "anticholinergic_bladder",
      "prevalence": "common",
      "severity": "high",
      "recommendation": "Anticholinergic directly opposes cholinesterase inhibitor. Worsens cognition in dementia patients. Consider behavioral interventions or mirabegron.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_03",
      "name": "NSAID → Hypertension → Antihypertensive",
      "trigger_drugs": ["naproxen", "ibuprofen", "meloxicam", "celecoxib", "indomethacin"],
      "trigger_class": "nsaid",
      "adverse_effect": "elevated_blood_pressure",
      "cascade_drugs": ["amlodipine", "lisinopril", "hydrochlorothiazide", "losartan"],
      "cascade_class": "antihypertensive",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "Discontinue NSAID if possible. Switch to acetaminophen or topical NSAID. Blood pressure often normalizes after NSAID discontinuation.",
      "pgx_relevance": "CYP2C9 poor metabolizers have increased NSAID exposure and higher hypertension risk"
    },
    {
      "id": "CASCADE_04",
      "name": "Metoclopramide → Parkinsonism → Levodopa",
      "trigger_drugs": ["metoclopramide"],
      "trigger_class": "prokinetic_dopamine_antagonist",
      "adverse_effect": "drug_induced_parkinsonism",
      "cascade_drugs": ["levodopa_carbidopa", "pramipexole", "ropinirole"],
      "cascade_class": "antiparkinson",
      "prevalence": "moderate",
      "severity": "high",
      "recommendation": "Discontinue metoclopramide. Parkinsonian symptoms typically resolve within weeks to months. Avoid unnecessary antiparkinson therapy.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_05",
      "name": "Thiazide Diuretic → Hyperuricemia/Gout → Allopurinol/Colchicine",
      "trigger_drugs": ["hydrochlorothiazide", "chlorthalidone", "indapamide"],
      "trigger_class": "thiazide_diuretic",
      "adverse_effect": "hyperuricemia_gout",
      "cascade_drugs": ["allopurinol", "colchicine", "febuxostat"],
      "cascade_class": "antigout",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "Consider switching antihypertensive if gout is new-onset after thiazide initiation. Losartan has mild uricosuric effect.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_06",
      "name": "SSRI → GI Bleeding → PPI",
      "trigger_drugs": ["sertraline", "fluoxetine", "paroxetine", "citalopram", "escitalopram"],
      "trigger_class": "ssri",
      "adverse_effect": "gi_symptoms_bleeding_risk",
      "cascade_drugs": ["omeprazole", "pantoprazole", "lansoprazole"],
      "cascade_class": "ppi",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "If GI symptoms appeared after SSRI initiation, consider switching to SNRI or mirtazapine. Long-term PPI has own risks (fractures, C. diff, hypomagnesemia).",
      "pgx_relevance": "CYP2C19 poor metabolizers have increased SSRI exposure. CYP2D6 status affects paroxetine and fluoxetine levels."
    },
    {
      "id": "CASCADE_07",
      "name": "Antipsychotic → Parkinsonism → Anticholinergic Antiparkinson",
      "trigger_drugs": ["haloperidol", "risperidone", "olanzapine"],
      "trigger_class": "antipsychotic",
      "adverse_effect": "extrapyramidal_symptoms",
      "cascade_drugs": ["benztropine", "trihexyphenidyl"],
      "cascade_class": "anticholinergic_antiparkinson",
      "prevalence": "common",
      "severity": "high",
      "recommendation": "Consider dose reduction of antipsychotic or switch to agent with lower EPS risk (quetiapine, aripiprazole). Adding anticholinergic worsens cognitive outcomes in elderly.",
      "pgx_relevance": "CYP2D6 poor metabolizers have increased haloperidol and risperidone exposure, increasing EPS risk"
    },
    {
      "id": "CASCADE_08",
      "name": "Opioid → Constipation → Laxative Escalation",
      "trigger_drugs": ["codeine", "tramadol", "oxycodone", "morphine", "hydrocodone", "fentanyl"],
      "trigger_class": "opioid",
      "adverse_effect": "constipation",
      "cascade_drugs": ["senna", "docusate", "bisacodyl", "polyethylene_glycol", "lactulose"],
      "cascade_class": "laxative",
      "prevalence": "very_common",
      "severity": "low",
      "recommendation": "Prophylactic laxative recommended with opioid initiation. If escalating laxatives needed, reassess opioid necessity and consider non-opioid alternatives.",
      "pgx_relevance": "CYP2D6 ultra-rapid metabolizers convert codeine/tramadol to active metabolites faster, potentially worsening constipation"
    },
    {
      "id": "CASCADE_09",
      "name": "Statin → Myalgia → Pain Medication",
      "trigger_drugs": ["simvastatin", "atorvastatin", "rosuvastatin", "pravastatin"],
      "trigger_class": "statin",
      "adverse_effect": "myalgia_myopathy",
      "cascade_drugs": ["naproxen", "ibuprofen", "acetaminophen", "gabapentin"],
      "cascade_class": "analgesic",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "Consider switching statin (pravastatin, fluvastatin have lower myopathy risk). NSAID adds GI and renal risk. Address root cause.",
      "pgx_relevance": "SLCO1B1 variants increase statin exposure and myopathy risk. Genotype-guided statin selection can prevent cascade."
    },
    {
      "id": "CASCADE_10",
      "name": "ACE Inhibitor → Cough → Cough Suppressant/Antibiotic",
      "trigger_drugs": ["lisinopril", "enalapril", "ramipril", "captopril"],
      "trigger_class": "ace_inhibitor",
      "adverse_effect": "dry_cough",
      "cascade_drugs": ["dextromethorphan", "codeine", "benzonatate", "azithromycin"],
      "cascade_class": "cough_treatment",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "ACE inhibitor cough occurs in 5-20% of patients. Switch to ARB (losartan, valsartan). Do not treat cough with suppressants or antibiotics.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_11",
      "name": "Corticosteroid → Hyperglycemia → Antidiabetic",
      "trigger_drugs": ["prednisone", "prednisolone", "dexamethasone", "methylprednisolone"],
      "trigger_class": "corticosteroid",
      "adverse_effect": "steroid_induced_hyperglycemia",
      "cascade_drugs": ["metformin", "glimepiride", "insulin"],
      "cascade_class": "antidiabetic",
      "prevalence": "common",
      "severity": "moderate",
      "recommendation": "If corticosteroid is being tapered or can be discontinued, hyperglycemia may resolve. Avoid adding long-acting sulfonylureas for steroid-induced glucose spikes.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_12",
      "name": "Gabapentinoid → Peripheral Edema → Diuretic",
      "trigger_drugs": ["gabapentin", "pregabalin"],
      "trigger_class": "gabapentinoid",
      "adverse_effect": "peripheral_edema",
      "cascade_drugs": ["furosemide", "hydrochlorothiazide"],
      "cascade_class": "diuretic",
      "prevalence": "moderate",
      "severity": "moderate",
      "recommendation": "Edema is known side effect of gabapentinoids. Consider dose reduction or switch to duloxetine for neuropathic pain rather than adding diuretic.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_13",
      "name": "Bisphosphonate → GERD → PPI",
      "trigger_drugs": ["alendronate", "risedronate", "ibandronate"],
      "trigger_class": "bisphosphonate",
      "adverse_effect": "esophagitis_gerd",
      "cascade_drugs": ["omeprazole", "pantoprazole"],
      "cascade_class": "ppi",
      "prevalence": "moderate",
      "severity": "moderate",
      "recommendation": "Ensure proper administration (upright for 30 min, full glass of water). Consider switching to IV bisphosphonate or denosumab. Chronic PPI may reduce bisphosphonate absorption.",
      "pgx_relevance": null
    },
    {
      "id": "CASCADE_14",
      "name": "Antidepressant → Weight Gain → Antidiabetic/Weight Loss Drug",
      "trigger_drugs": ["mirtazapine", "amitriptyline", "paroxetine", "olanzapine", "quetiapine"],
      "trigger_class": "psychotropic",
      "adverse_effect": "weight_gain_metabolic_syndrome",
      "cascade_drugs": ["metformin", "orlistat"],
      "cascade_class": "metabolic_agent",
      "prevalence": "moderate",
      "severity": "moderate",
      "recommendation": "Consider switching to weight-neutral antidepressant (sertraline, bupropion). Address root cause before adding metabolic medications.",
      "pgx_relevance": "CYP2D6 status affects paroxetine and amitriptyline metabolism; poor metabolizers at higher risk of weight gain due to increased drug exposure"
    },
    {
      "id": "CASCADE_15",
      "name": "Diuretic → Hypokalemia → Potassium Supplement",
      "trigger_drugs": ["furosemide", "hydrochlorothiazide", "bumetanide"],
      "trigger_class": "diuretic",
      "adverse_effect": "hypokalemia",
      "cascade_drugs": ["potassium_chloride"],
      "cascade_class": "electrolyte_supplement",
      "prevalence": "very_common",
      "severity": "low",
      "recommendation": "Consider adding potassium-sparing diuretic (spironolactone) instead of supplementation, or reassess diuretic necessity. If diuretic was added for CCB edema, both could potentially be removed.",
      "pgx_relevance": null
    }
  ]
}